drug toxicity

NAMs are increasingly used to de-risk preclinical development decisions, yet their broader impact on toxicology will depend on whether they are required or simply encouraged by regulators.

Drug discovery still relies on destroying cells to understand how they respond, but new real-time measurement approaches are beginning to reveal biology in motion rather than in snapshots.

Avoiding skin cancer could be as easy as slathering on a gel that the body rapidly metabolizes.

Automating liver cell counting adds a new layer of support for drug metabolism studies. 

Selective labeling of cancer stem cells with click chemistry-capable functional groups offers a new strategy for anticancer drug delivery.